.
.
.
.
Coronavirus

Russia’s Sputnik V COVID-19 vaccine 91.6 pct effective: Lancet

Published: Updated:

Russia’s Sputnik V vaccine is 91.6 percent effective against symptomatic COVID-19, according to an analysis published in The Lancet on Tuesday that independent experts said allayed transparency concerns over the jab, which Moscow is already rolling out.

For more coronavirus news, visit our dedicated page.

The preliminary findings show that the two-dose Sputnik V “has shown high efficacy” and was well tolerated for participants over 18 in final-stage clinical trials, said co-lead author Inna Dolzhikova of Russia’s Gamaleya National Research center for Epidemiology and Microbiology.

Read more:

Sputnik V vaccine explainer: Everything you need to know after UAE approval

Coronavirus: UAE approves Russia’s Sputnik COVID-19 vaccine for emergency use

Coronavirus: Pfizer or Sputnik? Immunization race prompts calls for choice